
--- Page 1 ---
Jcs-0 -3 Caicin`umu,mfHntrz ducp/ nrs 85oo/3 PATIENT HISTORY: Site : Srust, Nos CHIEF COMPLAINT/ PRE-OP/ POST-OP DIAGNOSIS: Lef breast cancer. c 50.9 3/28/ LMP DATE. Not applicable. PROCEDURE: Lent segmental mastectomy with wire localization, sentinel node biopsy and mapping. SPECIFIC CLINICAL QUESTION: Not provided. OUTSIDE TISSUE DIAGNOSIS: No PRIOR MALIGNANCY: No. CHEMORADIATION THERAPY: No. OTHER DISEASES: No FINAL DIAGNOSIS: Coloction Date. Part 1: Lymph node, Left axillA, Sentinel node #1, Biopsy -- ONE BENIGN LYmPH NODE, NO EVIDENCE OF mALIGNAnCY (0/1). Part 2: lymph node, Left AxillA, sentinel. node #2, siopsy - One senign Lymph nODe, NO eViDenCeE Of mALignAncy (0/1). Part 3: Breast, Left, segmental mastectomy with wire Localization - A.  InVASIVE DUCtAl CarciNOmA, NOTTINGhAm GRADE 2 (TUBULAR FORmATION: 3, nUCLEAR Pleomorphism: 2, mitotic Activity: 2; total Score 7/9). B. INvasive tumOr measures 1.5 Cm in GReAtest DimensiOn (GrOss Measurement). C.  LymphoVAsCULAR SPACe iNVAsION IS PreSENt. D. Ductal carcinoma in-situ (Dcis), nuclear grade 2, solid type.. E. .ResectiOn mArGiNs Are neGatIve fOr Carcinoma; Carcinoma IS 2 mm From nEareSt (ANTERIOR) MARGIN G. BIOPSY SITE CHANGES. H. CALCifIcaTiONs AssOciated wIth benIgn AnD maLignant AreaS.  TUmOR REPORTeD tO bE POsItIVe fOr eR AND PR, AnD nEgAtiVE fOR her-2/NEU J. rAIHOLOgIC STAGE: pT1a pN0. SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST LAteraLIty: Left PROCEDURE: Segmental LOCATION: Clock position:12:00 SIZE OF TUMOR:  Maximum dimension invasive component: 15 mm  MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive componont): No Ductal adenocarcinoma, NOS NOTTINGHAM SCORE: Nuclear grade: 2 Tubule formation: 3 Mitotic activity score: 2 Total Nottingham score: 7 Nottingham grade (1. 2. 3): 2 ANGIOLYMPHATIC INVASION: Yes  DERMAL LYMPHATIC INVASION: Nof applicable" CALCIFICATION: Yes, benign zones Yes, malignant zones Tumor type, in situ: Solid Percent of tumor occupied by in silu cornponent: 10 %. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: No Distance of invasive tumor to dosest margin: 3 mm SURG MARGINS INVOLVED BY IN SITU COMPONENT: No Distance of in situ disease to closest margin: 2 mm Lymph noDes POsitive: 0 Lymph NODeS EXAminED: 2 meThOD(S) Of Lymph NOdE eXAmiNAtiON: H/E stain t Stage, pathologic: pT1a N STAGE MODIFIER: (sn) N Stage, PathoLogIC: pN0 UUID:6AE92F6F-E29D-43B6-AF1E-F15720C1AAE8 Redacted M STAGE: Not applicable TCGA-BH-A201-01A-PR ESTROGEn RECEPTORS: positive, H-score: 205 PROGESTERONE RECEPTORS: positive, H-score: 225 HERZ/NEU: 1+